Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
04/05/1995 | EP0646376A1 Immunomodulating and antiinflammatory agent |
04/05/1995 | EP0646119A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
04/05/1995 | EP0646012A1 Wound healing and treatment of fibrotic disorders |
04/05/1995 | EP0593639B1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
04/05/1995 | EP0561948B1 Phosphonic acid derivatives useful as antiinflammatory agents |
04/05/1995 | EP0544812B1 Bisphosphonic acid derivatives as anti-arthritic agents |
04/05/1995 | EP0536169B1 [3H,7H]THIAZOLO [3,4-a]PYRIDINES WITH ANTIASTHMATIC AND ANTIINFLAMMATORY ACTIONS ON THE RESPIRATORY TRACT |
04/04/1995 | US5403953 1-phenylbicyclo[2.2.2]octane compounds |
04/04/1995 | US5403930 Substituted salicylic acids |
04/04/1995 | US5403857 Enzyme inhibitors, antiallergens, antiinflammatory agents |
04/04/1995 | US5403852 Oxazole derivatives, their preparation and pharmaceutical compositions containing them |
04/04/1995 | US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol |
04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
04/03/1995 | EP0672152A4 Fusion proteins comprising mgf and il-3. |
04/02/1995 | CA2133115A1 Carboxylate derivatives exhibiting phospholipase a2 inhibitory activity |
03/30/1995 | WO1995008570A1 Chimeric proteins which block complement activation |
03/30/1995 | WO1995008564A1 PEPTIDE DERIVATIVES OF α-MSH AND THEIR APPLICATION |
03/30/1995 | WO1995008549A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins |
03/30/1995 | WO1995008535A1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
03/30/1995 | WO1995008534A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases |
03/30/1995 | WO1995008347A1 Methods and products for controlling immune responses in mammals |
03/30/1995 | WO1995008338A1 Method for the treatment or prevention of eczema/dermatitis |
03/30/1995 | CA2172610A1 Chimeric proteins which block complement activation |
03/30/1995 | CA2172529A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins |
03/30/1995 | CA2172491A1 Method for the treatment or prevention of eczema/dermatitis |
03/30/1995 | CA2171448A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases |
03/29/1995 | EP0645376A1 Substituted 1-phenyl-oxazolidin-2-one derivatives, their preparation and their use as adhesion-receptor antagonists |
03/29/1995 | EP0645142A1 A novel physiologically active substance |
03/29/1995 | EP0644765A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1 |
03/29/1995 | EP0644764A1 Lipids for epidermal moisturization and repair of barrier function |
03/29/1995 | EP0644716A1 Medical uses of trioxolane and diperoxide compounds |
03/29/1995 | EP0569411B1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
03/29/1995 | EP0558563B1 Anti-inflammatory compounds |
03/29/1995 | CN1100633A Chondroprotective agents |
03/29/1995 | CN1100631A Chondroprotective agents |
03/28/1995 | US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments |
03/28/1995 | US5401777 Use of preparations of curcuma plants |
03/28/1995 | US5401765 For treating arthritis, pain and fever |
03/28/1995 | US5401750 Derivatives of substituted imidazol-2-one and process for their preparation |
03/28/1995 | US5401725 Treatment of tumors, rheumatoid arthritis and other diseases caused by vascular hyperplasia |
03/28/1995 | CA1334975C Furan and pyrrole containing lipoxygenase inhibiting compounds |
03/28/1995 | CA1334936C Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
03/24/1995 | CA2132579A1 Adhesion receptor antagonists iii |
03/23/1995 | WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine |
03/23/1995 | WO1995007934A2 Il8 inhibitors |
03/23/1995 | WO1995007922A1 Drug binding protein |
03/23/1995 | WO1995007908A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
03/23/1995 | WO1995007886A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
03/23/1995 | WO1995007711A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide |
03/23/1995 | WO1995003333A3 Tryptase inhibitor |
03/23/1995 | WO1994028897A3 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
03/23/1995 | CA2132568A1 Pharmaceutical compositions and usages |
03/22/1995 | EP0644198A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors |
03/22/1995 | EP0644197A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors |
03/22/1995 | EP0643968A1 Molded pharmaceutical form for oral delivery of acetylsalicyclic acid or its salts and method to prepare it |
03/22/1995 | EP0643716A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
03/22/1995 | EP0643712A1 Spiro-oxetanes, process for preparing the same and medicaments |
03/22/1995 | EP0643701A1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof |
03/22/1995 | EP0643585A1 A method for using lipoprotein associated coagulation inhibitor to treat sepsis |
03/22/1995 | EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
03/22/1995 | EP0561846B1 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
03/21/1995 | US5399703 Tetrazole derivatives and drugs |
03/21/1995 | US5399698 Quinolin-2-yl-methoxybenzylhydroxyureas |
03/21/1995 | US5399590 Treatment of skin tumors, rheumatic diseases |
03/21/1995 | US5399576 Thiazoles |
03/21/1995 | US5399563 Benzylidenequinuclidinones |
03/16/1995 | WO1995007364A1 Nucleic acid ligands and improved methods for producing the same |
03/16/1995 | WO1995007294A1 Pseudo- and non-peptide bradykinin receptor antagonists |
03/16/1995 | WO1995007291A1 Kininogen inhibitors |
03/16/1995 | WO1995007103A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
03/16/1995 | WO1995007091A1 Uses of vegetable oils |
03/16/1995 | WO1995007079A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
03/16/1995 | WO1995004528A3 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE |
03/16/1995 | WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof |
03/16/1995 | CA2170896A1 Kininogen inhibitors |
03/16/1995 | CA2170488A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
03/16/1995 | CA2169536A1 Nucleic acid ligands and improved methods for producing the same |
03/15/1995 | EP0643075A1 Novel peptide having elastase inhibitor activity and process for producing the same |
03/15/1995 | EP0642788A2 Tramadol salt containing medicaments with sustained release of the active ingredient |
03/15/1995 | EP0642577A1 Antibodies with specificity for multiple adhesion molecules |
03/15/1995 | EP0642521A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
03/15/1995 | EP0642520A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
03/15/1995 | EP0642519A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism |
03/15/1995 | EP0642517A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism |
03/15/1995 | EP0642516A1 Macrocyclic immunomodulators |
03/15/1995 | EP0642513A1 Indolocarbazole imides and their use |
03/15/1995 | EP0642504A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
03/15/1995 | EP0642489A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity |
03/15/1995 | EP0642356A1 Antibodies to p-selectin and their uses |
03/15/1995 | EP0642354A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R |
03/15/1995 | EP0642351A1 New pharmaceutical uses of krill enzymes |
03/15/1995 | EP0642348A1 Antibiotic cryptdin peptides and methods of their use |
03/15/1995 | EP0642336A1 Use of nsiad in the treatment of dementia |
03/15/1995 | EP0642332A1 Ophthalmic compositions containing a cyclosporin. |
03/15/1995 | EP0394333B1 Uses of sulphated sugars |
03/14/1995 | US5397778 Enteral formulations for treatment of inflammation and infection |
03/14/1995 | US5397774 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
03/14/1995 | US5397703 Method for generation of antibodies to cell surface molecules |
03/14/1995 | CA1334755C Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses |
03/14/1995 | CA1334753C Glycerin derivative and its pharmacological use |